Erbitux: profile and news
Gila Monster An Unlikely Help For Diabetics 06 Mar 2006
PITTSBURGH Deborah Keene of the South Hills knows all about diabetes, and now she’s using something that’s really changed her life – the new drug Byetta. ... - KDKA,
Diabetes Treatment Helps With Weight Loss 06 Mar 2006
The Eye on Health team spoke with a local diabetes specialist about the drug Byetta. The twice-daily injectable drug Byetta is prescribed for type-2 diabetics. ... - KLAS-TV,
Inhalable insulin holds promise 06 Mar 2006
Byetta, another new drug for treatment of diabetes, already is on the market. The FDA approved Eli Lilly and Amylin's Byetta for ... - Evansville Courier & Press (subscription),
Getting Even More Bullish On Byetta Feb 27, 2006
Piper Jaffray raised the price target on Amylin Pharmaceuticals and said a recent physician survey indicates sales growth for diabetes treatment Byetta may be ... - Forbes
Diabetes Drug Byetta Gaining Attention as Weight Loss Aid Mar 2, 2006
A new prescription diabetes drug that has only been on the market for nine months, Byetta (exenatide), is attracting a rapidly growing following because of its ... - Diet Drug Report,
Diabetics See Hope (and Weight Loss) in New Drug Mar 3, 2006
And the subject of their rhapsodies is not a gray-market diet pill sold on late-night television but Byetta, a medicine approved by US regulators that is ... - International News Service,
Amylin's Competitor Concerns For Byetta Seen Unwarranted Feb 6, 2006
Piper Jaffray said recent investor concerns regarding potential rivals to Amylin Pharmaceuticals' diabetes treatment Byetta were overblown and maintained an ... - Forbes
A Ray of Hope for Diabetics Mar 1, 2006
Byetta, a diabetes drug that was approved for marketing last April, has shown strong growth in the number of prescriptions written. ... - New York Times,
Amylin and Eli Lilly seek expanded diabetes approval Mar 3, 2006
...and Eli Lilly and Company have submitted a supplemental new drug application to the FDA for the expanded use of their diabetes medication Byetta injection. ... - Pharmaceutical Business Review
New Diabetes Drug Gains Fans Mar 2, 2006
Patients say Byetta has helped them lose weight and reverse many symptoms of diabetes, the New York Times reports. Byetta was introduced ... - International News Service,
Amylin Pharmaceuticals "outperform," target price raised - update Feb 28, 2006
...note published yesterday, the analysts mention that a recent survey on the current prescribers indicates that the adoption of the company’s Byetta drug is ... - New Ratings
Amylin Pharmaceuticals Reports 2005 Financial Results Feb 9, 2006
We launched two first-in-class products, BYETTA and SYMLIN, both of which are growing in their acceptance by health care providers, patients, and payors," said ... - MSN Money
Reptile revelation Feb 22, 2006
...can lead healthier lives. The drug, called Byetta, is just one of several advances for those with diabetes. Roughly 18.2 million ... - Washington Times,
Home loan applications dip Mar 2, 2006
...it has submitted a supplemental new drug application to the Food and Drug Administration, seeking approval for expanded use of its diabetes drug, Byetta, as a ... - San Diego Union Tribune,
Partnering is common in drug industry Feb 26, 2006
Lilly products that required critical work from partners include the insulins Humulin and Humalog; two diabetes medicines, Actos and Byetta; and the male ... - Indianapolis Star,
Latest Diabetes ZOOM Market Report(TM) Released Mar 3, 2006
Byetta has been launched in the US, with a sales message focusing on its unique benefits as first-to-market in a new class of diabetes drugs. ... - Yahoo! News (press release)
Drug sales: Lilly product surprises analysts Feb 7, 2006
Its latest entrant, the diabetes drug Byetta, continues to impress less than a year after coming on the market. During the last ... - Indianapolis Star,
Amylin's Exenatide LAR Pricing In Half Of Stock's Value Feb 13, 2006
..."We remain cautious on the stock as optimism over strong Byetta sales is offset by the ... Byetta is co-marketed by Eli Lilly and was approved last April. - Forbes
Gila monster venom used to make effective diabetes drug Feb 10, 2006
A powerful protein in its saliva is now the basis of a new and highly successful diabetes drug called Byetta. It's injected twice a day before meals. ... - San Antonio Express (subscription),
Strong Sales for Amylin Feb 9, 2006
Amylin has two drugs that help diabetics control their blood sugar levels - Symlin, which Amylin markets by itself, and Byetta, whose marketing and development ... - TheStreet.com
(PRN) - EFJ, Inc. 2005 Q4 and Full Year Earnings Call Scheduled ... Mar 1, 2006
Vice President ... [+. PRN) - Supplemental New Drug Application for BYETTA Submitted to FDA for Use With TZDs ... [+. PRN) - NeoRx ... - Bolsamania.com,
Amylin Pharmaceuticals sees Q4 loss at 60 cents to 63 cents Feb 10, 2006
...in a news release, said its fourth quarter activities included increased investment in Exenatide LAR, an extended release version of its diabetes drug Byetta. ... - ABC News
Lilly launches new diabetes product Feb 8, 2006
Lilly. This isn't Lilly's only new diabetes product; the company is also experiencing success with the recently launched Byetta. ... - Pharmaceutical Business Review
Gila Monster Saliva Helps Diabetes Patients Feb 15, 2006
Protein found in the lizard's saliva has been added to a drug called Byetta and it is injected into the patent twice a day before meals. ... - Local6.com,
Merck Gets Ahead in Diabetes Feb 15, 2006
Amylin Pharmaceuticals already has a GLP-1-like drug called Byetta on the market, which is derived from the saliva of a desert reptile known as a Gila monster ... - Red Herring,
Biotech Investing for the Long Haul Feb 22, 2006
...diabetes drugs, such as Pfizer's PFE and Nektar's NKTR inhaled insulin Exubera and Amylin's AML N non-insulin injectable drugs Symlin and Byetta, give patients ... - Morningstar.com,
Merck's Januvia Has 'Huge' Commercial Potential For Diabetes Feb 23, 2006
In addition, Rubin said DPP-IV inhibitors could appeal to a broader group of primary care patients compared with Byetta, a potent diabetes drug marketed by ... - Forbes
Recent Deals, New Technologies and Regulatory Updates to Be ... Feb 24, 2006
The keynote presentations will cover Pfizer's outlook and recent deals in the macromolecule markets, and about Amylin's success story with Byetta. ... - Market Wire (press release)
IMS Health Reports 5.4 Percent Dollar Growth in 2005 US ... Feb 22, 2006
Among the notable new products launched in 2005 were several potential blockbusters (over $1 billion in annual sales), including Eli Lilly's Byetta(tm) (for ... - PharmaLive.com (press release),
Stock Strategist: Biotech Investing for the Long Haul Feb 22, 2006
New types of diabetes drugs, such as Pfizer's and Nektar's inhaled insulin Exubera and Amylin's non-insulin injectable drugs Symlin and Byetta, give patients ... - TMCnet
Eye On Stocks For Friday, Feb. 10 Feb 9, 2006
The company reported sales of diabetes treatment Byetta, co-marketed by Eli Lilly (nyse: LLY - news - people ), of $49.7 million, compared with analysts ... - Forbes
Drug firm welcomed to West Chester Feb 6, 2006
Amylin has developed and gained approval for two first-in-class medicines for diabetes: Symlin (pramlintide acetate) injection and Byetta (exenatide) injection ... - Cincinnati Business Courier,
Inhalable Drug Might Bring Sigh Of Relief To Diabetes Patients Feb 10, 2006
Exubera will compete against traditional insulin as well as against a new twice-a-day injectable insulin called Byetta, which is made through a partnership ... - Investor's Business Daily (subscription)
